A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD)

Administered By

Awarded By

Contributors

Start/End

  • March 1, 2015 - February 28, 2017